Low BMI and low TSH value as risk factors related to lower bone mineral density in postmenospausal women under levothyroxine therapy for differentiated thyroid carcinoma

OBJECTIVE: Treatment of differentiated thyroid carcinoma (DTC) includes suppression of TSH with levothyroxine therapy, which may negatively influence bone mineral density (BMD), but the effects are controversial. We aimed to evaluate the relationship between TSH-suppressive therapy and BMD in postme...

Descripción completa

Detalles Bibliográficos
Autores principales: de Melo, Thaís Gomes, da Assumpção, Lígia Vera Montalli, Santos, Allan de Oliveira, Zantut-Wittmann, Denise Engelbrecht
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4474343/
https://www.ncbi.nlm.nih.gov/pubmed/26097507
http://dx.doi.org/10.1186/s13044-015-0019-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4474343/
https://www.ncbi.nlm.nih.gov/pubmed/26097507
http://dx.doi.org/10.1186/s13044-015-0019-1

Ejemplares similares